A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Erlotinib

Need help?
media.product.imagealternatetextformat.details

Erlotinib Methoxy Impurity

N° de SZ CAT: SZ-E018039
Número CAS
1312937-41-9
Mol.F.
C15H20N2O5
Peso Molecular
308.3
Status de Fatura
In Stock

Nome Químico: 4-Methoxy-6,7-bis(2-methoxyethoxy)quinazoline

Shipping Temperature:

HSN Code: 38229010

Country of Origin: India

Sorrisos: COCCOC1=C(OCCOC)C=C(N=CN=C2OC)C2=C1

Erlotinib Methoxy Impurity is chemically 4-Methoxy-6,7-bis(2-methoxyethoxy)quinazoline. Erlotinib Methoxy Impurity is supplied with detailed characterization data compliant with regulatory guideline. Erlotinib Methoxy Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erlotinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

🔍

Search by Keywords

Buy 1312937-41-9 Purchase 1312937-41-9 Order 1312937-41-9 Enquire 1312937-41-9 Price of 1312937-41-9 1312937-41-9 Supplier 1312937-41-9 Manufacturer 1312937-41-9 Exporter Buy high quality Erlotinib Methoxy Impurity Purchase Erlotinib Methoxy Impurity Erlotinib Methoxy Impurity suppliers Erlotinib Methoxy Impurity manufacturers Erlotinib Methoxy Impurity price Erlotinib Methoxy Impurity exporter Order Erlotinib Methoxy Impurity Enquire Erlotinib Methoxy Impurity Erlotinib Methoxy Impurity cost Erlotinib Methoxy Impurity Supplier Erlotinib Methoxy Impurity Distributor
ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

,